BioSpace News Archive

Hemogenyx Pharmaceuticals plc, the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that the U.S. Food and Drug Administration has accepted the Company’s plan to address the FDA’s concerns that resulted in a Clinical Hold of the HEMO-CAR-T Investigational New Drug application.

Medivir AB announces that the company will present at the Pareto Securities Healthcare Conference.

Bionomics Limited announced an update on the company’s α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator collaboration with MSD.

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced it will host its fifth annual Spatial Genomics Summit, September 19th.

The CDMO expands its AGCellerate Program to provide Lentiviral vector support for advanced therapies developers

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, is hosting an Investor Day beginning at 1:00 p.m. ET today in New York City, expected to conclude by approximately 4:00 p.m. ET.

Aclipse Therapeutics announced today that it has signed an exclusive license agreement with Seoul, South Korea-based Chong Kun Dang Pharmaceutical Corporation (“CKD”).

Anavex Life Sciences Corp. announced today that a follow-on analysis of the landmark Phase 2b/3 study to treat early Alzheimer’s disease with the investigational drug blarcamesine (ANAVEX ® 2-73) did demonstrate a statistically significant slowing in cognitive decline associated with Alzheimer’s disease.

Coeptis Therapeutics Holdings, Inc. today provided a safety and patient dosing update from two Phase 1 clinical trials investigating DVX201 for the treatment of relapsed/refractory acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) and patients hospitalized with COVID-19 infection.

FluidAI Medical, a leading artificial intelligence (AI) startup and developer of the Stream™ Platform for post-surgical monitoring, has announced a strategic partnership with Medtronic Canada ULC, a prominent subsidiary of the global healthcare technology company, Medtronic PLC.